MIBC Clinical Trials in Baltimore, Maryland
2 recruitingBaltimore, Maryland
Showing 1–2 of 2 trials
Recruiting
Phase 2
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Low-grade NMIBCFGFR Gene AmplificationFGFR Gene Alterations+3 more
Tyra Biosciences, Inc90 enrolled35 locationsNCT06995677
Recruiting
Not Applicable
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
Bladder CancerMuscle Invasive Bladder Cancer (MIBC)Muscle Invasive Bladder Cancer Urothelial Carcinoma+1 more
Johns Hopkins University130 enrolled2 locationsNCT07225205